Uterine Neoplasms
Information
- Disease name
- Uterine Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02820506 | Active, not recruiting | N/A | Sentinel Node Mapping in Women With Endometrial and Cervical Cancer | February 27, 2017 | January 31, 2026 |
| NCT04579380 | Active, not recruiting | Phase 2 | Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | January 11, 2021 | May 31, 2025 |
| NCT00090389 | Completed | Phase 1 | Acupuncture for Women's Health Conditions | January 2005 | May 2007 |
| NCT00100191 | Completed | Phase 3 | Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids | February 2002 | April 2006 |
| NCT00112307 | Completed | N/A | Magnetic Resonance Imaging Guided Gynecologic Brachytherapy | March 2003 | October 2005 |
| NCT00188578 | Completed | Phase 1/Phase 2 | Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) | June 2003 | June 2014 |
| NCT00188695 | Completed | Phase 1/Phase 2 | Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide | April 2004 | March 15, 2022 |
| NCT00190918 | Completed | Phase 2 | A Trial for Patients With Gestational Trophoblastic Disease | July 2006 | July 2007 |
| NCT00190983 | Completed | Phase 2 | A Trial for Patients With Advanced/Recurrent Cervical Cancer | February 2005 | October 2007 |
| NCT00231855 | Completed | Phase 2 | Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers | November 2004 | March 2007 |
| NCT00250783 | Completed | Pre-Clinical Models in Gynecological Tumors A Tissue Repository | July 2002 | January 2008 | |
| NCT00361036 | Completed | Phase 1 | Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | August 2006 | March 2010 |
| NCT00377520 | Completed | Phase 2 | A Trial for Patients With Advanced/Recurrent Endometrial Cancer | September 2006 | September 2008 |
| NCT00628901 | Completed | Phase 4 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | January 2006 | January 2011 |
| NCT00050440 | Completed | Phase 2 | Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | July 2002 | July 2004 |
| NCT00087841 | Completed | Phase 2 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | April 2002 | November 2006 |
| NCT01654458 | Completed | N/A | A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | July 2012 | September 2019 |
| NCT02374411 | Completed | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | September 2014 | March 2015 | |
| NCT02444195 | Completed | N/A | Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients | April 2015 | May 1, 2016 |
| NCT02454036 | Completed | Phase 2 | Biobehavioral Intervention in Gynecologic Oncology Patients | June 2015 | May 18, 2017 |
| NCT02528864 | Completed | MRI and Metabolomics Biomarkers for Uterine Malignancy | August 1, 2015 | July 31, 2018 | |
| NCT02825355 | Completed | Sentinel Node Mapping in Women With Cervical and Endometrial Cancer | February 27, 2017 | May 1, 2022 | |
| NCT04351139 | Completed | Impact of the COVID-19 Pandemic in Gynecological Oncology | May 6, 2020 | November 30, 2020 | |
| NCT04679675 | Completed | N/A | Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | November 20, 2020 | July 29, 2023 |
| NCT05004623 | Completed | N/A | Early Feasibility Study of the "Easy Light" Fluorecence Imaging System | May 26, 2021 | August 6, 2021 |
| NCT04061967 | Recruiting | N/A | SMS-based Summons in Cervical Screening | August 19, 2019 | June 1, 2030 |
| NCT03624712 | Recruiting | Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | January 2012 | December 2024 | |
| NCT05242861 | Recruiting | Retrospective Study of Brachytherapy | February 20, 2022 | December 31, 2027 | |
| NCT00782041 | Terminated | Phase 2 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | January 2003 | |
| NCT00505492 | Terminated | Phase 2 | Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | February 2002 | December 2010 |
| NCT00669422 | Terminated | ChemoFx® PRO - A Post-Market Data Collection Study | October 2006 | October 2012 | |
| NCT01998854 | Terminated | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | February 2013 | January 2015 | |
| NCT01969396 | Terminated | N/A | Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology | October 2013 | September 2014 |
| NCT04063072 | Unknown status | N/A | ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. | September 1, 2019 | October 31, 2021 |
| NCT01564264 | Unknown status | N/A | Sentinel Node Biopsy in Endometrial Cancer | November 2012 | December 2014 |
| NCT03951415 | Unknown status | Phase 2 | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer | July 8, 2019 | August 1, 2021 |
| NCT03971032 | Unknown status | N/A | An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure | December 31, 2019 | May 2021 |
| NCT00250770 | Withdrawn | Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis | January 1998 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014594